TITLE

Increased incidence of cutaneous malignant melanoma among longshoremen in Genoa, Italy: the role of sunlight and occupational exposure

AUTHOR(S)
Puntoni, R.; Ceppi, M.; Casella, C.; Ugolini, D.; Gennaro, V.; Puntoni, M.; Vercelli, M.; Merlo, D. F.
PUB. DATE
April 2005
SOURCE
Occupational & Environmental Medicine;Apr2005, Vol. 62 Issue 4, p270
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor about the aetiological role of sunlight and artificial sources of ultraviolet radiation on the occurrence of cutaneous malignant melanoma.
ACCESSION #
16789570

 

Related Articles

  • Expression of CD117 in Primary Anorectal Malignant Melanoma. Laforga, Juan B.; Gasent, Joan M. // Archives of Pathology & Laboratory Medicine;Feb2009, Vol. 133 Issue 2, p176 

    A letter to the editor is presented in response to the article "Expression of melanoma antigens in epithelioid gastrointestinal stromal tumors: a potential diagnostic pitfall," by ML Guler, JA Daniels, SC Abraham, and EA Montgomery in the 2008 issue.

  • Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk. Thirumaran, Ranjit K.; Thoelke, Adina; Ugurel, Selma; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv // JNCI: Journal of the National Cancer Institute;9/6/2006, Vol. 98 Issue 17, p1252 

    A letter to the editor is presented in response to the article "Association between endothelin receptor B non-synonymous variants and melanoma risk," by B. N. Soufir and colleagues, which appeared in a 2005 issue of the "Journal of the National Cancer Institute."

  • RESPONSE. Soijfir, Nadem // JNCI: Journal of the National Cancer Institute;9/6/2006, Vol. 98 Issue 17, p1253 

    A response by the authors to a letter to the editor about their article "Association between endothelin receptor B non-synonymous variants and melanoma risk," which appeared in a 2005 issue of the "Journal of National Cancer Institute" is presented.

  • Melanoma Cancer. Hege, Enas // Saturday Evening Post;Jul/Aug87, Vol. 259 Issue 5, p8 

    Presents a letter to the editor about melanoma cancer.

  • Ipilimumab plus Dacarbazine in Melanoma.  // New England Journal of Medicine;9/29/2011, Vol. 365 Issue 13, p1256 

    A letter to the editor is presented in response to an article about the addition of ipilimumab to dacarbazine chemotherapy as a first-line therapy for metastatic melanoma by Robert and colleagues, published in the June 30, 2011 issue.

  • Melanoma in Children. Bono, Aldo; Bartoli, Cesare; Del Prato, Ivan // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p255 

    A letter to the editor is presented in response to the article "Melanoma in Children," by Ceballos, Ruiz-Maldonado, and Mihm in the March 9, 1995 issue.

  • Melanoma in Children. Pappo, Alberto S.; Pratt, Charles B. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p255 

    A letter to the editor is presented in response to the article "Melanoma in Children," by Ceballos, Ruiz-Maldonado, and Mihm in the March 9, 1995 issue.

  • Melanoma in Children. Ceballos, Patricia I.; Ruiz-Maldonado, Ramon; Mihm, Martin C. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p255 

    A response by Ceballos, Ruiz-Maldonado, and Mihm to several letters to the editor about their article "Melanoma in Children" in the March 9, 1995 issue is presented.

  • Malignant melanoma. Schwartz, Stephen D. // Journal of Dermatologic Surgery & Oncology;May/Jun77, Vol. 3 Issue 3, p246 

    Presents a letter to the editor about malignant melanomas.

  • Capital Letters. Breslow, Alexander // Journal of Dermatologic Surgery & Oncology;May/Jun77, Vol. 3 Issue 3, p246 

    Presents a letter to the editor about Malignant Melanoma: A Review.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics